# "Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"

> **NCT05543161** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Myeloid Leukemia, Chronic Phase

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05543161
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05543161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05543161, ""Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05543161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*